SLIDE 1
Drugs Used In The Management Of Atrial Fibrillation Dr Steve - - PowerPoint PPT Presentation
Drugs Used In The Management Of Atrial Fibrillation Dr Steve - - PowerPoint PPT Presentation
Drugs Used In The Management Of Atrial Fibrillation Dr Steve Murray Consultant EP & Cardiologist Outline of session Unfortunately individual cases cannot and will not be discussed! Beta-blockers Calcium channel blockers
SLIDE 2
SLIDE 3
Vaughn-Williams Classification
I - sodium channel blockers II - Beta blockers III – Potassium channel blockade IV – calcium channel blockers Ia – e.g procainamide Ib – e.g. lignocaine Ic – e.g. flecainide III – e.g. Amiodarone, dofetilide NB Sotalol is II and III
SLIDE 4
Beta blockers
Propranolol Metoprolol Acebutalol Labetalol Atenolol Oxprenolol Sotalol Esmolol Bisoprolol
SLIDE 5
Beta Blockers – decrease sympathetic tone Action Antagonise the effects of catecholamines (hormones like adrenaline) on the heart.
- They block beta adrenoreceptors, hence
name (duh!)
- Catecholamines, via the so-called
sympathetic nervous system, are like the “accelerator” on heart and blood vessels
SLIDE 6
Beta-receptors
There are many different types of beta- receptor, but basically some are more prevalent in the heart, and others in the lung However, they are found basically everywhere in the body
SLIDE 7
Side effects
Slow pulse, too low blood pressure, cold hands/toes, tiredness/lethargy Dose-dependent on which beta blocker used, and varies between individuals
SLIDE 8
Uses
Good for AF rate control (NICE 1st line) May prevent/reduce attacks of paroxysmal AF in patients with catecholamine- sensitive triggers Some used in heart failure treatment (bisoprolol, carvedilol) – a concept that was heresy only as far back as 1995
SLIDE 9
Verapamil – Calcium (Ca) Antagonist
Action
Inhibits slow inward Ca current in smooth muscle and cardiac cells, Slows AV node conduction [main ‘junction box’ in the heart... ... Hence slows ventricular response to atrial fibrillation/flutter May suppress Sinus node function [natural pacemaker]
SLIDE 10
Other points to consider
Has negative inotropic effect – i.e. decreases force of contraction in the heart Caution... ...if patient has received beta blocker! Also care required in patients with poor myocardial function- hypotension or VT
SLIDE 11
Uses
Good for prevention of SVT, but does not prevent AF. Excellent rate control for AF in those unable to take Beta-blockers Good drug to combine with Digoxin, but not beta-blockers
SLIDE 12
Verapamil – Bluffer’s guide
Like all Calcium channel blockers, Verapamil is in Vaughn-Williams Class IV It primarily acts on AV node and His- purkinje system
SLIDE 13
Other calcium channel blockers
Diltiazem – very similar to verapamil Amlodipine – little effect on heart conduction, better on relaxing arteries, hence excellent for Blood pressure treatment, and useless for rate control
SLIDE 14
Vaughn-Williams Classification
I - sodium channel blockers II - Beta blockers III – Potassium channel blockade IV – calcium channel blockers Ia – e.g procainamide Ib – e.g. lignocaine Ic – e.g. flecainide III – e.g. Amiodarone, dofetilide NB Sotalol is II and III
SLIDE 15
Cardiac Action Potential – a bit like a toilet flush!
Chain pulled, loo flushes Cistern just about refilled You might manage a new flush anywhere about here
SLIDE 16
Flecainide- Class 1c Antiarrhythmic
Action Binds to sodium channel, decreases speed of depolarisation (phase 1 of action potential) Slows conduction in the atria, His-purkinje fibres, accessory pathways and ventricles Causes slight prolongation of QRS complex, but not QT interval
SLIDE 17
Effect of Flecainide
SLIDE 18
Flecainide
Effective and safe in treatment of atrial fibrillation with structurally normal hearts However effects often wane after 2 or 3 years for some patients...
SLIDE 19
Flecainide – bluffer’s guide
F1ecainide – class Ic For ‘Action’ think:
for AF, it’s like tadpoles (AF wavelets) swimming in water (spreading across the atria); flecainide turns the pond water into syrup!
SLIDE 20
Caution!
Due to negative inotropic effect should be avoided in patients with heart failure (but see below anyway) Can be pro arrhythmic – especially in LV dysfunction and acute ischaemia Can paradoxically worsen atrial arrhythmias – slowing of atrial rate may facilitate 1:1 conduction of flutter
SLIDE 21
Side effects Visual disturbance Light headedness nausea Can increase pacing threshold in those with pacemakers implanted
SLIDE 22
Amiodarone- Class III Antiarrhythmic
Action “Broad spectrum” antiarrhythmic highly effective in treatment of supraventricular and ventricular rhythm disorders Utterly over-used, especially by non- cardiologists! Prolongs refractoriness (makes cells lazier)
SLIDE 23
Effect of Amiodarone
SLIDE 24
Amiodarone – Bluffer’s guide
Class III drug Think: after flushing your toilet, it takes longer to re-fill the cistern, so you cannot flush it again quite so quickly Most amiodarone in the body just ‘hangs around’ in muscles doing nothing... ...active drug in blood is a small fraction
SLIDE 25
Caution! Sinus bradycardia Thyroid dysfunction Iodine sensitivity Pregnancy
SLIDE 26
Side Effects
Reversible corneal deposits (disappear if drug stopped) Skin photosensitivity/slate grey skin discoloration Hypo/hyperthyroidism Lung fibrosis Bradycardia and conduction disturbances Can effect liver function Can effect renal function/thrombocytopenia Nausea, rash, alopecia, tremor, insomnia, nightmares
SLIDE 27
Other points to consider
Can potentiate warfarin Can increase blood levels of digoxin, quinidine and flecainide Liver function, thyroid function test required before treatment and every 6 months Chest X ray performed prior to commencing drug
SLIDE 28
Half Life 2 weeks to 3 months Dosage (oral) Loading dose often required Action may take 1-3 weeks to occur even after loading doses
SLIDE 29
Drodenarone
Amiodarone without the side effects! May become ‘gold standard’ in AF, but... ...possibly less good in AF with heart failure.
SLIDE 30
Digoxin
Enhances vagal tone [the “brakes” on the heart via the so-called parasymptathetic nervous system] Vagal tone is withdrawn first at the onset
- f exercise...
...hence Digoxin is not a great 1st line treatment in active patients
SLIDE 31
Digoxin
Most of the drug ‘hangs around in muscles” doing nothing, with small fraction in blood that is active Hence interacts with amiodarone Too much is poisonous! Works extremely well in combination with verapamil
SLIDE 32
Digoxin is weakly positively inotropic...
In other words it has a weak tonic effect on the heart... ...this is in contrast to every other anti- arrhythmic drug
SLIDE 33
Warfarin
Block Vitamin K in the gut, which is required to make clotting factors INR is a ratio as to how much longer the blood will take to clot as compared to ‘normal’ (an average) Works in the liver, where clotting factors are made... ...hence influenced by other drugs and foods!
SLIDE 34
Aspirin
Makes platelets less sticky Has no effect on clotting factors
SLIDE 35
Summary
All anti-arrhythmic drugs act by altering conduction in the heart. The receptors and nerves influenced by these drugs are often found in other tissues outside the heart...hence side effects
SLIDE 36
Summary
Some important drugs ‘fill up seats’ in muscles or fat tissue doing nothing, and it’s only when all the ‘seats are taken’ that the drug spills out into blood where it is active. Some drugs ‘compete for these seats’ and thus can influence active levels of each
- ther
SLIDE 37
Thank you
SLIDE 38
Adenosine
Action
Blocks AV node conduction Shortens atrial refractoriness – “recover quicker/less lazy” (hence may promote AF) May have some effect on SA node
SLIDE 39
Adenosine - Uses
Clinically:
Terminate SVTs via nodal block Differentiate VT (NB at high enough dose) Unmask a latent accessory pathway
In EP lab:
May aid in assessing a septal concealed accessory pathway
SLIDE 40
Adenosine – miscellanea
May terminate around:
15% of automatic atrial tachycardias 10-15% of fascicular VT 10-15% RVOT VT 5-10% typical atrial flutter
Beware the ‘rebound sympathetic drive’ and resultant sinus tachycardia!
SLIDE 41
Caution!
May cause sinus bradycardia, which may be more prolonged in patients with sick sinus syndrome In patients with asthma may cause bronchospasm (but this is rare, and often over- played) It should only be given with crash trolley to hand
- and with this caveat, it is safe to give to pre-
excited AF in my opinion
SLIDE 42
Half Life - 20-30seconds Side Effects Chest tightness Dyspnoea Flushing Patient may experience impending sense
- f doom
Administration-Rapid bolus, with defib on hand
SLIDE 43
Adenosine doses
Manufacturer’s recommended Dose:- Rapid 3mg bolus, if no reversion to sinus rhythm after 1 min give 6mg, then 12mg, then 18mg this is the maximum dose Real life: Start at least at 6mg, and ‘personal best’ is 36mg
SLIDE 44
Atropine
Action Blocks vagal stimulation – hence may alleviate vagally-mediated bradycardia & vaso-vagal symptoms in lab NB it will not reverse heart block due to conduction tissue disease, or damage from RF!
SLIDE 45
When would we use it in the lab?
If patient has vagal event i.e during vascular access / following sheath removal May aid initiation of SVT (“slick-up” the AV node)
SLIDE 46